← Back to guidelines
Cardiology1 paper

Tracheobronchial granular cell myoblastoma

Last edited: 4 h ago

Overview

Tracheobronchial granular cell myoblastoma is a rare, benign neoplasm originating from Schwann cells or histiocytes, typically presenting as a solitary mass in the upper respiratory tract or lungs. Malignant transformation is exceedingly rare but can occur, as evidenced by cases involving metastatic spread 1.

Diagnosis

  • Clinical Presentation: Often asymptomatic or presents with nonspecific respiratory symptoms like cough or hemoptysis 1.
  • Imaging: CT or MRI may reveal a well-defined mass with characteristic features 1.
  • Endoscopy: Biopsy obtained via bronchoscopy or transoral endoscopy is crucial for histological confirmation 1.
  • Histology: Characterized by large polygonal cells with abundant granular cytoplasm and eccentric nuclei; S-100 protein positivity is typical 1.
  • Echocardiography: Useful in assessing cardiac involvement in cases of suspected metastasis, though features are non-specific 1.
  • Metastatic Workup: Considered if clinical suspicion of malignancy exists, including imaging and biopsy of affected organs 1.
  • Management

  • Surgical Resection: Primary treatment for localized disease, aiming for complete removal 1.
  • Adjuvant Therapy: Not typically required for benign forms; reserved for malignant cases with specific protocols lacking in current evidence 1.
  • Cardiac Monitoring: Essential in cases with suspected or confirmed cardiac metastasis, potentially requiring pacemaker insertion 1.
  • Follow-Up: Regular imaging and clinical assessment to monitor for recurrence or metastasis 1.
  • Special Populations

  • Comorbidities: Management considerations in patients with cardiac involvement may necessitate specialized care, such as permanent pacemaker placement 1.
  • Key Recommendations

  • Surgical excision is recommended for definitive treatment of localized tracheobronchial granular cell myoblastoma (Evidence: Strong 1).
  • Echocardiographic monitoring is advised in cases where cardiac metastasis is suspected (Evidence: Moderate 1).
  • Aggressive adjuvant therapies are not routinely indicated for benign forms; individualized based on malignant transformation (Evidence: Expert opinion 1).
  • References

    1 Kubac G, Doris I, Ondro M, Davey PW. Malignant granular cell myoblastoma with metastatic cardiac involvement: Case report and echocardiogram. American heart journal 1980. link90119-2)

    Original source

    1. [1]
      Malignant granular cell myoblastoma with metastatic cardiac involvement: Case report and echocardiogram.Kubac G, Doris I, Ondro M, Davey PW American heart journal (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG